The Effect of Mirror Therapy Applied to Stroke Patients on Motor-Sensory Status and Quality of Life

NCT ID: NCT06963762

Last Updated: 2025-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-31

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: The research will be conducted to evaluate the effect of Mirror Therapy applied to Stroke Patients on motor-sensory status and quality of life.

Method: The research will be carried out as a randomized controlled experimental study at Bilecik Training and Research Hospital and Bozüyük State Hospital between 01.08.2024-01.05.2025. The population of the research consists of 350 people. Individuals will be distributed to the experimental (30) and control (30) groups by simple randomization method. In collecting research data; The patient introduction form, Brunnstrom Staging and SF-36 Quality of Life Scale will be administered to the patients in both groups by the researcher using face-to-face interview technique (pre-test). Patients in the experimental group will be informed about mirror therapy.

In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks.

Patients in the control group will only receive conventional rehabilitation for 30 minutes, 4 times a week for 4 weeks. At the end of the 4th week, patients in both groups will be administered Brunnstrom Staging and SF-36 Quality of Life Scale (posttest).

If both groups are discharged before 4 weeks, the planned practices will continue at home.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Mirror Movement Therapy Rehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

conventional rehabilitation group

Group Type EXPERIMENTAL

Conventional rehabilitation will be applied

Intervention Type BEHAVIORAL

Conventional rehabilitation will be applied for 30 minutes, 4 times a week for 4 weeks.

group receiving mirror therapy along with conventional rehabilitation

Group Type EXPERIMENTAL

Mirror therapy will be applied along with conventional rehabilitation

Intervention Type BEHAVIORAL

In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Conventional rehabilitation will be applied

Conventional rehabilitation will be applied for 30 minutes, 4 times a week for 4 weeks.

Intervention Type BEHAVIORAL

Mirror therapy will be applied along with conventional rehabilitation

In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Being literate,
2. Being over the age of 18,
3. Having sufficient communication skills to answer oral and written questions and follow instructions,
4. Having been diagnosed with a stroke and at least 6 days have passed since it occurred,
5. Not having severe vision problems,
6. Not having a vertigo problem,
7. Not having been diagnosed with epilepsy,
8. Upper extremity Stage 2 and above in Brunnstrom staging
9. Lower extremity Stage 2 and above in Brunnstrom staging

Exclusion Criteria

1. Being under 18 years of age
2. Upper extremity Stage 2 and below in Brunnstrom staging
3. In Brunnstrom staging, Lower extremity Stage 2 and below
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ataturk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AHMET ŞİMŞEK

PhD student

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ATAÜNİ-SBE-AS-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Robot-Assisted Therapy in Chronic Stroke Patients
NCT06692829 NOT_YET_RECRUITING NA